SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-17-029086
Filing Date
2017-05-23
Accepted
2017-05-23 16:35:47
Documents
2
Effectiveness Date
2017-05-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A v467676_defa14a.htm DEFA14A 40747
2 GRAPHIC image_001.jpg GRAPHIC 3763
  Complete submission text file 0001144204-17-029086.txt   47081
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37758 | Film No.: 17864201
SIC: 2834 Pharmaceutical Preparations